Pancreatic neuroendocrine tumors: tailoring imaging to specific clinical scenarios

Katerina S. Konstantinoff; Ajaykumar C. Morani; Thomas A. Hope; Priya R. Bhosale; Isaac R. Francis; Motoyo Yano; Amir Iravani Tabrizipour; Nikolaos A. Trikalinos; Malak Itani

doi:10.1007/s00261-022-03737-5

Pancreatic neuroendocrine tumors: tailoring imaging to specific clinical scenarios

Katerina S. Konstantinoff, Ajaykumar C. Morani, Thomas A. Hope, Priya R. Bhosale, Isaac R. Francis, Motoyo Yano, Amir Iravani Tabrizipour, Nikolaos A. Trikalinos, Malak Itani

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

The clinical and imaging presentation of pancreatic neuroendocrine tumors (PanNETs) is variable and depends on tumor grade, stage, and functional status. This degree of variability combined with a multitude of treatment options and imaging modalities results in complexity when choosing the most appropriate imaging studies across various clinical scenarios. While various guidelines exist in the management and evaluation of PanNETs, there is an overall lack of consensus and detail regarding optimal imaging guidelines and protocols. This manuscript aims to fill gaps where current guidelines may lack specificity regarding the choice of the most appropriate imaging study in the diagnosis, treatment planning, monitoring, and surveillance of PanNETs under various clinical scenarios.

Original language	English
Pages (from-to)	1843-1853
Number of pages	11
Journal	Abdominal Radiology
Volume	48
Issue number	5
DOIs	https://doi.org/10.1007/s00261-022-03737-5
State	Published - May 2023

Keywords

CT
Imaging
MRI
Pancreatic neuroendocrine neoplasm
Somatostatin receptor PET

Access to Document

10.1007/s00261-022-03737-5

Cite this

@article{b29e6589113740648258fea218ae5a07,

title = "Pancreatic neuroendocrine tumors: tailoring imaging to specific clinical scenarios",

abstract = "The clinical and imaging presentation of pancreatic neuroendocrine tumors (PanNETs) is variable and depends on tumor grade, stage, and functional status. This degree of variability combined with a multitude of treatment options and imaging modalities results in complexity when choosing the most appropriate imaging studies across various clinical scenarios. While various guidelines exist in the management and evaluation of PanNETs, there is an overall lack of consensus and detail regarding optimal imaging guidelines and protocols. This manuscript aims to fill gaps where current guidelines may lack specificity regarding the choice of the most appropriate imaging study in the diagnosis, treatment planning, monitoring, and surveillance of PanNETs under various clinical scenarios.",

keywords = "CT, Imaging, MRI, Pancreatic neuroendocrine neoplasm, Somatostatin receptor PET",

author = "Konstantinoff, {Katerina S.} and Morani, {Ajaykumar C.} and Hope, {Thomas A.} and Bhosale, {Priya R.} and Francis, {Isaac R.} and Motoyo Yano and {Iravani Tabrizipour}, Amir and Trikalinos, {Nikolaos A.} and Malak Itani",

note = "Publisher Copyright: {\textcopyright} 2023, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.",

year = "2023",

month = may,

doi = "10.1007/s00261-022-03737-5",

language = "English",

volume = "48",

pages = "1843--1853",

journal = "Abdominal Radiology",

issn = "2366-004X",

number = "5",

}

TY - JOUR

T1 - Pancreatic neuroendocrine tumors

T2 - tailoring imaging to specific clinical scenarios

AU - Konstantinoff, Katerina S.

AU - Morani, Ajaykumar C.

AU - Hope, Thomas A.

AU - Bhosale, Priya R.

AU - Francis, Isaac R.

AU - Yano, Motoyo

AU - Iravani Tabrizipour, Amir

AU - Trikalinos, Nikolaos A.

AU - Itani, Malak

PY - 2023/5

Y1 - 2023/5

N2 - The clinical and imaging presentation of pancreatic neuroendocrine tumors (PanNETs) is variable and depends on tumor grade, stage, and functional status. This degree of variability combined with a multitude of treatment options and imaging modalities results in complexity when choosing the most appropriate imaging studies across various clinical scenarios. While various guidelines exist in the management and evaluation of PanNETs, there is an overall lack of consensus and detail regarding optimal imaging guidelines and protocols. This manuscript aims to fill gaps where current guidelines may lack specificity regarding the choice of the most appropriate imaging study in the diagnosis, treatment planning, monitoring, and surveillance of PanNETs under various clinical scenarios.

AB - The clinical and imaging presentation of pancreatic neuroendocrine tumors (PanNETs) is variable and depends on tumor grade, stage, and functional status. This degree of variability combined with a multitude of treatment options and imaging modalities results in complexity when choosing the most appropriate imaging studies across various clinical scenarios. While various guidelines exist in the management and evaluation of PanNETs, there is an overall lack of consensus and detail regarding optimal imaging guidelines and protocols. This manuscript aims to fill gaps where current guidelines may lack specificity regarding the choice of the most appropriate imaging study in the diagnosis, treatment planning, monitoring, and surveillance of PanNETs under various clinical scenarios.

KW - CT

KW - Imaging

KW - MRI

KW - Pancreatic neuroendocrine neoplasm

KW - Somatostatin receptor PET

UR - http://www.scopus.com/inward/record.url?scp=85147348764&partnerID=8YFLogxK

U2 - 10.1007/s00261-022-03737-5

DO - 10.1007/s00261-022-03737-5

M3 - Article

C2 - 36737523

AN - SCOPUS:85147348764

SN - 2366-004X

VL - 48

SP - 1843

EP - 1853

JO - Abdominal Radiology

JF - Abdominal Radiology

IS - 5

ER -

Pancreatic neuroendocrine tumors: tailoring imaging to specific clinical scenarios

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this